{"transactions":[{"id":671067,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-01T20:05:16.000Z","date":"2026-08-28","kind":"grant","planned":false,"acquired":true,"shares":54690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest quarterly in substantially equal installments over a three-year period, subject to the Reporting Person's continuous service as of each vesting date, The first 1/12 tranche shall vest immediately upon the grant date with the remaining 11/12 vesting equally over the following 11 quarters starting on the three-month anniversary of the grant date."}],"balance_after":54690,"derivative":{"exercise_price":2.12,"expiration_date":"2036-08-27","underlying":"Common Stock","underlying_shares":54690},"source":{"system":"sec-edgar","filing":"0001140361-26-035317","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000114036126035317/form4.xml","form_type":"4"}},{"id":1170995,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-17T00:58:52.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests quarterly in substantially equal installments over a 3-year period, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":2.08,"expiration_date":"2035-04-14","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001140361-25-014265","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000114036125014265/form4.xml","form_type":"4"}},{"id":1523296,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-05-08T23:19:03.000Z","date":"2024-05-06","kind":"grant","planned":false,"acquired":true,"shares":25380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period."}],"balance_after":25380,"derivative":{"exercise_price":2.96,"expiration_date":"2034-05-06","underlying":"Class A Common Shares","underlying_shares":25380},"source":{"system":"sec-edgar","filing":"0000950170-24-056083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000095017024056083/ownership.xml","form_type":"4"}},{"id":1827806,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-07-18T20:34:18.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options granted on 07/14/2023 under the Acasti Pharma Stock Option Plan, which vest and become exercisable in equal quarterly installments over a period of 36 months."}],"balance_after":60000,"derivative":{"exercise_price":2.64,"expiration_date":"2033-07-14","underlying":"Class A Common Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001062993-23-014997","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000106299323014997/form4.xml","form_type":"4"}},{"id":3590596,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-03-18T21:59:49.000Z","date":"2019-03-15","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of RSUs granted to the Reporting Person on August 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-19-011943","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000112760219011943/form4.xml","form_type":"4"}},{"id":3590595,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-18T21:59:49.000Z","date":"2019-03-15","kind":"exercise","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of RSUs granted to the Reporting Person on August 14, 2018."}],"balance_after":580602,"source":{"system":"sec-edgar","filing":"0001127602-19-011943","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000112760219011943/form4.xml","form_type":"4"}},{"id":3843344,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2018-08-15T12:12:39.000Z","date":"2018-08-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-18-025379","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000112760218025379/form4.xml","form_type":"4"}},{"id":3887197,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":true}}],"security":"Stock Option (Right To Purchase)","published_at":"2018-06-20T20:35:31.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options shall become exercisable upon the achievement of certain performance or time based criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These options expire on the third anniversary of the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":1.1,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001127602-18-021589","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000112760218021589/form4.xml","form_type":"4"}},{"id":3985093,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":true,"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-03-22T20:03:07.000Z","date":"2018-03-22","kind":"sale","acquired":false,"shares":2500,"price":16.41,"value":41025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $16.25 to $16.56 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":570602,"source":{"system":"sec-edgar","filing":"0001127602-18-012504","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000112760218012504/form4.xml","form_type":"4"}},{"id":3986420,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":true,"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-03-21T15:34:18.000Z","date":"2018-03-21","kind":"sale","acquired":false,"shares":2500,"price":16.52,"value":41300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $16.42 to $16.58 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":573102,"source":{"system":"sec-edgar","filing":"0001127602-18-012359","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000112760218012359/form4.xml","form_type":"4"}},{"id":3986419,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":true,"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-03-21T15:34:18.000Z","date":"2018-03-20","kind":"sale","acquired":false,"shares":5000,"price":16.47,"value":82350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $16.21 to $16.86 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":575602,"source":{"system":"sec-edgar","filing":"0001127602-18-012359","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000112760218012359/form4.xml","form_type":"4"}},{"id":3986418,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":true,"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-03-21T15:34:18.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":2500,"price":16.66,"value":41650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $16.50 to $16.97 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":580602,"source":{"system":"sec-edgar","filing":"0001127602-18-012359","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000112760218012359/form4.xml","form_type":"4"}},{"id":4040587,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":true,"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-02-22T22:00:56.000Z","date":"2018-02-22","kind":"sale","acquired":false,"shares":2500,"price":14.49,"value":36225.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.23 to $14.76 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":583102,"source":{"system":"sec-edgar","filing":"0001127602-18-007774","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000112760218007774/form4.xml","form_type":"4"}},{"id":4040586,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":true,"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-02-22T22:00:56.000Z","date":"2018-02-21","kind":"sale","acquired":false,"shares":5000,"price":13.82,"value":69100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.68 to $14.05 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":585602,"source":{"system":"sec-edgar","filing":"0001127602-18-007774","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000112760218007774/form4.xml","form_type":"4"}},{"id":4040585,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":true,"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-02-22T22:00:56.000Z","date":"2018-02-20","kind":"sale","acquired":false,"shares":5000,"price":13.75,"value":68750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.66 to $13.86 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":590602,"source":{"system":"sec-edgar","filing":"0001127602-18-007774","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000112760218007774/form4.xml","form_type":"4"}},{"id":4384597,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":true,"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right To Purchase)","published_at":"2017-03-15T19:36:32.000Z","date":"2017-03-13","kind":"grant","acquired":true,"shares":110000,"price":8.86,"value":974600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 110,000 shares of Common Stock, will become exercisable on February 17, 2018, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":110000,"derivative":{"exercise_price":8.86,"expiration_date":"2027-03-13","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001127602-17-011770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000112760217011770/form4.xml","form_type":"4"}},{"id":4481917,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":true,"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right To Purchase)","published_at":"2017-01-25T14:35:13.000Z","date":"2017-01-23","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 100,504 shares of Common Stock, became exercisable on June 1, 2014, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":75504,"derivative":{"exercise_price":2.04,"expiration_date":"2023-10-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001127602-17-002309","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000112760217002309/form4.xml","form_type":"4"}},{"id":4481916,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":17928,"kind":"person","name":"Macdonald R. Loch","position":1,"cik":"0001653008","reported_name":"Macdonald R. Loch","relationship":{"director":true,"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-01-25T14:35:13.000Z","date":"2017-01-23","kind":"exercise","acquired":true,"shares":25000,"price":2.04,"value":51000.0,"ownership":{"direct":true},"balance_after":595602,"source":{"system":"sec-edgar","filing":"0001127602-17-002309","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653008/000112760217002309/form4.xml","form_type":"4"}}]}